[CERT] Ernexa Therapeutics Inc. Certification Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

CERT

Rhea-AI Filing Summary

Analyzing...

02/05/2026 - 03:11 PM

CERT - Ernexa Therapeutics Inc.

CERT Filing - Ernexa Therapeutics Inc.

This filing is available as a PDF document.

Filing Type: CERT

Company: Ernexa Therapeutics Inc. (ERNA)

Acceptance Date: 2026-02-05T15:11:47.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Ernexa

NASDAQ:ERNA

ERNA Rankings

#6515 Ranked by Market Cap

N/A Ranked by Dividends

ERNA Latest News

Feb 3, 2026

Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA

Jan 27, 2026

Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program

Jan 6, 2026

Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer

Dec 8, 2025

Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer

Dec 3, 2025

Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting

ERNA Latest SEC Filings

Feb 5, 2026

[S-1/A] Ernexa Therapeutics Inc. Amends IPO Registration Statement

Feb 3, 2026

[S-1/A] Ernexa Therapeutics Inc. Amends IPO Registration Statement

Feb 2, 2026

[S-1] Ernexa Therapeutics Inc. Files IPO Registration Statement

Nov 7, 2025

[10-Q] Ernexa Therapeutics Inc. Quarterly Earnings Report

Aug 18, 2025

[SCHEDULE 13G/A] Ernexa Therapeutics Inc. SEC Filing

ERNA Stock Data

Market Cap 6.66M

Float 2.62M

Insiders Ownership 59.71%

Institutions Ownership 0.65%

Short Percent 0.59%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City CAMBRIDGE